The following table highlights certain deliverables described in the law.  As FDA works with stakeholders to implement the provisions of the law, additional deliverables may be identified. See DSCSA Guidances for more information.

Section of DSCSA	Deliverable Type	Deliverable Description
202	FR Notice	Issue notice of public docket to collect stakeholder comments on standards for interoperable exchange of transaction information/history/statement in paper or electronic format
202	Guidance	Publish draft guidance establishing standards for interoperable exchange of transaction information/history/statement in paper or electronic format
202	Guidance	Publish guidance on processes for waivers, exceptions, exemptions
202	Guidance	Publish final guidance on grandfathering product
203	Assessment	Conduct and complete a technology and software assessment on feasibility of small dispensers to conduct drug tracing at the package level
203	Guidance	Publish guidance on identification of suspect product and termination of notifications of illegitimate product for finished human prescription drugs
203	Public Meeting	Conduct at least 5 public meetings
203	Pilot Project	Establish 1 or more pilot projects in coordination with stakeholders to explore and evaluate methods to enhance the safety and security of supply chain
203	Guidance	Publish final guidance on system attributes necessary to enable secure tracing at the package level
203	Guidance	Publish final guidance on standards for interoperable data exchange to enhance secure tracing of product at the package level
204	Database	Establish a system for wholesale drug distributor reporting to FDA and public database with licensing information
204	Regulation	Develop regulations establishing standards for licensing of wholesale drug distributors
205	Database	Establish a system for third-party logistic provider reporting to FDA
205	Regulation	Develop regulations establishing standards for licensing of third-party logistic providers